Compare NTAP & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTAP | WST |
|---|---|---|
| Founded | 1992 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 25.8B |
| IPO Year | 1996 | 2004 |
| Metric | NTAP | WST |
|---|---|---|
| Price | $162.77 | $357.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $116.58 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 2.8M | 675.8K |
| Earning Date | 05-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.91% | 0.30% |
| EPS Growth | ★ 11.99 | 1.49 |
| EPS | ★ 6.35 | 1.92 |
| Revenue | ★ $6,237,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $6.22 | $6.76 |
| Revenue Next Year | $4.91 | $6.22 |
| P/E Ratio | ★ $25.83 | $186.74 |
| Revenue Growth | ★ 5.59 | 1.95 |
| 52 Week Low | $93.69 | $206.80 |
| 52 Week High | $192.83 | $367.66 |
| Indicator | NTAP | WST |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 64.64 |
| Support Level | $95.25 | $259.17 |
| Resistance Level | $164.66 | $367.66 |
| Average True Range (ATR) | 6.44 | 8.20 |
| MACD | -0.03 | -0.67 |
| Stochastic Oscillator | 50.27 | 75.48 |
NetApp Inc is storage hardware provider into a software-driven, cloud-centric data infrastructure company. Its flagship ONTAP data management software, together with a comprehensive portfolio of all-flash, hybrid-flash, and cloud-native solutions, forms the backbone of digital transformation for thousands of enterprises world'wide. Its operations are organized into two segments Hybrid Cloud and Public Cloud. It generates majority of revenue from Hybrid Cloud offers a unified data storage portfolio of storage management and infrastructure solutions that helps customers modernize their data centers. Hybrid Cloud includes software, hardware, and related support, along with professional and other services. It generates majority of revenue from United States followed by International market.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.